Innovator IBD Breakout Opportunities ETF (NYSEARCA:BOUT) Stock Price Up 2.7% – Here’s What Happened

Innovator IBD Breakout Opportunities ETF (NYSEARCA:BOUT)’s share price shot up 2.7% on Monday . The company traded as high as $36.70 and last traded at $36.70. 955 shares traded hands during mid-day trading, a decline of 50% from the average session volume of 1,924 shares. The stock had previously closed at $35.73.

Innovator IBD Breakout Opportunities ETF Stock Performance

The firm’s 50-day moving average is $38.06 and its two-hundred day moving average is $37.13. The stock has a market cap of $11.21 million, a P/E ratio of 28.69 and a beta of 1.08.

Hedge Funds Weigh In On Innovator IBD Breakout Opportunities ETF

Several large investors have recently made changes to their positions in the company. Osaic Holdings Inc. lifted its position in Innovator IBD Breakout Opportunities ETF by 39.7% during the 2nd quarter. Osaic Holdings Inc. now owns 2,102 shares of the company’s stock valued at $77,000 after purchasing an additional 597 shares during the period. Comprehensive Wealth Management LLC lifted its holdings in Innovator IBD Breakout Opportunities ETF by 60.5% in the third quarter. Comprehensive Wealth Management LLC now owns 10,544 shares of the company’s stock valued at $411,000 after buying an additional 3,976 shares during the period. Susquehanna International Group LLP lifted its holdings in Innovator IBD Breakout Opportunities ETF by 42.6% in the third quarter. Susquehanna International Group LLP now owns 26,176 shares of the company’s stock valued at $1,020,000 after buying an additional 7,817 shares during the period. Finally, Nova Wealth Management Inc. boosted its stake in Innovator IBD Breakout Opportunities ETF by 109.4% in the first quarter. Nova Wealth Management Inc. now owns 23,978 shares of the company’s stock valued at $870,000 after acquiring an additional 12,528 shares during the last quarter.

About Innovator IBD Breakout Opportunities ETF

The Innovator IBD Breakout Opportunities ETF (BOUT) is an exchange-traded fund that is based on the IBD Breakout Stocks Total Return index. The fund tracks an index of US-listed stocks that are likely to breakout, as determined by technical analysis. Holdings are weighted by a mix of fundamental and technical factors BOUT was launched on Sep 13, 2018 and is managed by Innovator.